Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep81 | Adrenal cortex (to include Cushing's) | ECE2017

Long term follow up of patients with adrenal incidentaloma and ‘autonomous cortisol secretion’

Kraljevic Ivana , Solak Mirsala , Dusek Tina , Polovina Tanja Skoric , Balasko Annemarie , Kastelan Darko

The aim of this study was to compare the long-term co-morbidities and biochemical data between patients with adrenal incidentaloma and ‘autonomous cortisol secretion’ who were treated surgically and conservatively.Methods: The research of the database of the patients with adrenal incidentaloma diagnosed between 2007 and 2014 was performed. Among them, 43 patients with ‘autonomous cortisol secretion’ were identified and invited for a f...

ea0081rc7.1 | Rapid Communications 7: Pituitary and Neuroendocrinology 2 | ECE2022

Does the postoperative dose of hydrocortisone influence the health-related quality of life in patients with cured Cushing syndrome?

Kraljevic Ivana , Barac Anja , Solak Mirsala , Skoric Polovina Tanja , Balasko Annemarie , Zibar Tomsic Karin , Dusek Tina , Kastelan Darko

Objective: Patients with Cushing syndrome (CS) have impaired health-related quality of life (HRQoL) before and after surgery. The data on the optimal hydrocortisone dose after surgical cure of CS is scarce. Therefore, we investigated the influence of hydrocortisone dose on HRQoL after surgical treatment of CS. We hypothesized that patients who receive higher hydrocortisone doses after surgery would have better HRQoL and fewer cortisol withdrawal symptoms.<p class="abstext"...

ea0063p1092 | Pituitary and Neuroendocrinology 3 | ECE2019

Factors predicting dopamine agonist treatment withdrawal in prolactinoma patients

Solak Mirsala , Haxhiu Arta , Haxhiu Arita , Kraljevic Ivana , Dusek Tina , Leskovar Dunja , Polovina Tanja Skoric , Balasko Annemarie , Kastelan Darko

Aim: Dopamine agonist (DA) therapy is recommended as first-line treatment for prolactinomas, albeit with long treatment duration and high recurrence rate after treatment withdrawal. The aim of this retrospective study was to evaluate predictors for successful DA withdrawal.Methods: The study included 59 prolactinoma patients (39 female, 20 male; age 34 (18–82) years) that were treated with DA (35.6% on cabergoline); the duration of treatment was 71 ...

ea0049ep71 | Adrenal cortex (to include Cushing's) | ECE2017

Neutrophil-lymphocyte and platelet-lymphocyte ratios as biomarkers in distinguishing adrenocortical adenomas and carcinomas

Solak Mirsala , Kraljevic Ivana , Kastelan Marko , Kakarigi Luka , Dusek Tina , Polovina Tanja Skoric , Balasko Annemarie , Knezevic Nikola , Kastelan Darko

The role of systemic inflammation in promoting tumor progression has been a topic of increasing interest. Neutrophil-lymphocyte ratio (NLR) >5 and platelet-lymphocyte ratio (PLR) >190 used as indicators of inflammation have been reported to have prognostic value in numerous solid tumors. The aim of this retrospective study was to investigate NLR and PLR as biomarkers in distinguishing between adrenocortical adenomas and adrenocortical carcinomas (ACC). Nineteen patient...

ea0056p855 | Pituitary - Clinical | ECE2018

Hypopituitarism in primary empty sella

Tomsic Karin Zibar , Deskin Marin , Kraljevic Ivana , Dusek Tina , Solak Mirsala , Polovina Tanja Skoric , Balasko Annemarie , Kastelan Darko

Empty sella is characterized by the radiological appearance of an enlarged or deformed sella turcica which is completely or partially filled with cerebrospinal fluid resulting in a displacement of the normal pituitary gland. Primary empty sella (PES) refers to the empty sella appearance of unknown etiology, diagnosed after excluding a history of previous pituitary pathology. The prevalence of hypopituitarism in empty sella syndrome varies between 2 and 32% in different publish...

ea0099ep29 | Calcium and Bone | ECE2024

The usefulness of 18F-choline PET/CT in patients with negative findings on 99mTc-sestamibi SPECT/CT in Locating Hyperfunctioning Parathyroid Glands in Primary Hyperparathyroidism

Mandic Ante , Kraljevic Ivana , Skoric Polovina Tanja , Zibar Tomsic Karin , Dusek Tina , Balasko Annemarie , Solak Mirsala , Kastelan Darko

Objective: This study aimed to investigate the diagnostic performance of 18F-choline PET/CT in patients with negative or inconclusive results of 99mTc-sestamibi SPECT/CT in locating hyperfunctioning parathyroid tissue in primary hyperparathyroidism patients.Methods: We conducted a retrospective study involving patients who were operated on due to primary hyperparathyroidism from April 2019 to March 2022. The analysis focused on pati...

ea0099ep140 | Pituitary and Neuroendocrinology | ECE2024

Long-term outcomes of non-functioning pituitary macroadenomas following surgery

Solak Mirsala , Kraljevic Ivana , Brekalo Roman , Skoric Polovina Tanja , Balasko Annemarie , Zibar Tomsic Karin , Popovac Hrvoje , Dusek Tina , Kastelan Darko

Background: Systematic or randomised studies on the natural course of non-functioning pituitary macroadenomas after surgery (NFPA) are lacking.Objectives: This study aimed to evaluate the long-term outcomes of residual NFPA following pituitary surgery.Methods: In this retrospective study, we included 130 patients with NPFA who underwent pituitary surgery between 2005 and 2018 at University Hospital Centre Zagreb. The median age of ...

ea0081p694 | Pituitary and Neuroendocrinology | ECE2022

Radiological classification of craniopharyngioma based on its origin

Skoric Polovina Tanja , Ozretic David , Solak Mirsala , Kraljevic Ivana , Dusek Tina , Balasko Annemarie , Zibar Tomšić Karin , Kastelan Darko

Recognizing the site of origin of craniopharyngioma (CP) along the hypothalamus-pituitary axis according to pre-operative MR is helpful to understand its growth pattern in relation to hypothalamus, which is critical in the prediction of hypothalamic injury and planning of treatment. We retrospectively classified 29 CP according to MR pre-operative image study using modified classification of Tang et al. (Nature, 8:10215, 2018). According to its relation to pituitary s...

ea0081ep648 | Pituitary and Neuroendocrinology | ECE2022

Medical treatment of active acromegaly - the results from the Croatian Acromegaly Registry

Sambula Lana , Solak Mirsala , Kraljevic Ivana , Popovac Hrvoje , Polovina Tanja Skoric , Zibar Tomšić Karin , Dusek Tina , Balasko Annemarie , Kastelan Darko

Background: The aim of this study was to evaluate the outcomes of medical treatment in patients with active acromegaly.Material and Methods: We performed a retrospective analysis of 163 patients (101 female, age at diagnosis 47.2&pm;13.4 years) treated between 1990 and 2020., of which 53 were on medical treatment (32.5%). Remission rate after pituitary surgery was 66.5% (n=105/158; 5 patients refused surgery). Patients who did not achieve remiss...

ea0090ep676 | Pituitary and Neuroendocrinology | ECE2023

Early postoperative growth hormone measurement as a predictor of surgical remission of acromegaly

Kraljevic Ivana , Kovač Diana , Solak Mirsala , Skoric Polovina Tanja , Zibar Tomšić Karin , Balasko Annemarie , Dusek Tina , Kastelan Darko

Purpose: To evaluate the value of early postoperative growth hormone (GH) as a predictor of surgical remission of acromegaly.Methods: We conducted a retrospective search through our database of patients who underwent transsphenoidal surgery for GH-secreting pituitary adenoma from 2011 to June 2022. Only patients who underwent the first pituitary surgery and had GH measurements on the fifth postoperative day were included. The surgical remission was defin...